Abstract

 Our patient is a 2-year-old previously healthy boy presenting with fever and a generalized rash. A completed blood count at his initial presentation showed a platelet count of 29,000 cu.mm. He was found to have coronavirus 229 E on the respiratory viral panel by multiplex PCR.

Keywords: Immune Thrombocytopenic Purpura (ITP); Coronavirus Infection; Epstein-Barr Virus

References

1. ITP A. “Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy”. British Journal of Haematology 1 (2003): 574-596.
2. McMillan R., et al. “Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)”. Journal of Thrombosis and Haemostasis3 (2003): 485-491.
3. Semple J. “Immune pathophysiology of autoimmune thrombocytopenic purpura”. Blood Reviews1 (2002): 9-12.
4. Zhou B., et al. “Multi-dysfunctional pathophysiology in ITP”. Critical Reviews in Oncology/Hematology2 (2005): 107-116.
5. Filion MC., et al. “Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane antigen present on bone marrow-derived cells”. Blood 6 (1996): 2144-2150.
6. Liu B., et al. “Abnormality of CD4+ CD25+ regulatory T cells in idiopathic thrombocytopenic purpura”. European Journal of Haematology2 (2007): 139-143.
7. Nimmerjahn F and JV Ravetech. “Fcꭚ receptors as regulators of immune responses”. Native Reviews Immunology1 (2008): 34.
8. Lee CY., et al. “Acute immune thrombocytopenic purpura in an adolescent with 2009 novel H1N1 influenza A virus infection”. Journal of the Chinese Medical Association9 (2011): 425-427.
9. Tilden W and S Valliani. “Severe thrombocytopenia and recurrent epistaxis associated with primary Epstein-Barr virus infection”. Case Reports (2015).
10. Flores-Chang BS., et al. “Immune thrombocytopenic purpura secondary to cytomegalovirus infection: a case report”. Frontiers in Medicine 2 (2015): 79.
11. George JN., et al. “Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology”. Blood1 (1996): 3-40.
12. Provan D., et al. “International consensus report on the investigation and management of primary immune thrombocytopenia”. Blood 2 (2010): 168-186.
13. Stasi R and D Provan. “Management of immune thrombocytopenic purpura in adults”. In Mayo Clinic Proceedings (2004).
14. Rodeghiero F., et al. “Treatment practices in adults with chronic immune thrombocytopenia - a European perspective”. European Journal of Haematology 2 (2010): 160-168.

Citation

Citation: Rana Sharara-Chami., et al. “Immune Thrombocytopenic Purpura Secondary to Coronavirus Infection”. Acta Scientific Paediatrics 3.6 (2020): 19-22.

Copyright

Copyright: © 2020 Rana Sharara-Chami., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.